Evidence map›Paper›PMID 39495763›Full record

ArticlePloS one2024

Single-step hydrothermal synthesis of zinc oxide nanorods for potential use as nano-antibiotics without seeding or bases.

Chau Nguyen Minh Hoang, Khanh Duy Nguyen, Thuong Thi Ha Luong, Son Hai Nguyen, Mai Thi Tran

Abstract read
In one paragraph

Article in PloS one, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Chau Nguyen Minh HoangVinUni-Illinois Smart Health Center, VinUniversity, Hanoi, Vietnam.
Khanh Duy NguyenCollege of Health Science, VinUniversity, Hanoi, Vietnam.
Thuong Thi Ha LuongCollege of Health Science, VinUniversity, Hanoi, Vietnam.
Son Hai NguyenSchool of Mechanical Engineering, Hanoi University of Science and Technology, Hanoi, Vietnam.
Mai Thi TranVinUni-Illinois Smart Health Center, VinUniversity, Hanoi, Vietnam.ORCID 0000-0002-7993-5735

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The alarming global rise in antibiotic resistance, driven by the widespread overuse of traditional antibiotics, has created an urgent demand for new antimicrobial solutions. This study presents zinc oxide (ZnO) nanorods as a potential nano-antibiotic agent. ZnO nanorods, with a 2:3 aspect ratio, were synthesized using an efficient one-step hydrothermal method at a low temperature of 100°C, reducing the synthesis time to just 5 hours. The synthesized ZnO nanorods' morphology, structure, and composition were characterized using scanning electron microscopy, x-ray diffraction, and energy dispersive x-ray spectroscopy. The potent antimicrobial activity of these nanorods against common bacterial strains such as Escherichia coli, Bacillus subtilis, and Vibrio parahaemolyticus was examined through optical density at 600 nm (OD600) measurements and inhibition zone analysis, demonstrating substantial inhibition of bacterial growth. In particular, at a concentration of 5 mg/mL, ZnO nanorods achieved a 96% reduction of B. subtilis bacteria in OD600 and an impressive 99.87% reduction in culturing assays within one day, showcasing bactericidal efficiency on par with tetracycline at 0.003 mg/mL. Furthermore, a predictive model of bacterial growth was developed and validated, providing insights into the time-dependent bactericidal efficiency of the synthesized nanorods. These results highlight the potential of ZnO-based composites as a promising solution to combat antibiotic resistance, paving the way for next-generation antimicrobial materials.

Indexed as

Anti-Bacterial AgentsBacillus subtilisEscherichia coliNanotubesZinc OxideMicrobial Sensitivity TestsVibrio parahaemolyticusX-Ray DiffractionAnti-Bacterial AgentsZinc Oxide

Identifiers

PMID39495763
PMCPMC11534225

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.